PAPER
Application of a Thermal b-Elimination Reaction to N-Alkoxy-3,3-dinitroisoxazolidines
709
3
perature for 7 d. The solvent was evaporated and the residue was
dissolved in CHCl3. The product was isolated after column chroma-
tography (CHCl3–PE, 1:2).
1H NMR (CDCl3): d = 1.21 (t, J = 7.1 Hz, 3 H, CH3), 1.24 (t,
3J = 7.1 Hz, 3 H, CH3), 3.42 [dd, J = 17.9, J = 11.7 Hz, 1 H,
2
3
2
CH2C(NO2)], 3.54–3.69 (m, 2 H, OCH2CH3), 3.59 [dd, J = 17.9,
3J = 7.3 Hz, 1 H, CH2C(NO2)], 3.73–3.83 (m, 2 H, OCH2CH3), 4.61
[d, 3J = 3.4 Hz, 1 H, CH(OEt)2], 5.06 (ddd, 3J = 3.4, 7.3, 11.7 Hz, 1
H, CHO).
Yield: 0.56 g (58%); oil; Rf 0.73 (CHCl3).
1H NMR (CDCl3): d = 1.31–2.05 (m, 20 H, c-Hex), 3.11 [d,
2J = 15.0 Hz, 1 H, CH2C(NO2)2], 3.63 [d, 2J = 15.0 Hz, 1 H,
CH2C(NO2)2], 4.50 (d, 2J = 12.0 Hz, 1 H, CH2NO2), 4.71 (d,
2J = 12.0 Hz, 1 H, CH2NO2).
13C NMR (CDCl3): d = 15.2 (CH3), 15.9 (CH3), 30.8 [CH2C(NO2)],
63.9 (CH2O), 65.6 (CH2O), 87.5 (CH), 101.1 (CH), 163.8 [C(NO2)].
Anal. Calcd for C8H14N2O5: C, 44.03; H, 6.47; N, 12.84. Found: C,
43.92; H, 6.48; N, 12.82.
13C NMR (CDCl3): d = 22.4 (2 × CH2), 23.7 (2 × CH2), 24.4 (CH2),
24.5 (CH2), 31.5 (CH2), 32.0 (CH2), 36.3 (CH2), 39.4 (CH2), 42.8
[CH2C(NO2)2], 79.7 (CH2NO2), 84.5 (C), 91.1 (C), 128.3
[C(NO2)2].
3-Nitro-4,5-dihydroisoxazole-5-carbonitrile (6b)9
Solid; mp 132 °C (Lit.9 mp 132 °C).
Anal. Calcd for C15H24N4O8: C, 46.39; H, 6.23. Found: C, 46.74; H,
5.97.
2
3
1H NMR (DMSO-d6): d = 3.92 [dd, J = 17.4, J = 7.1 Hz, 1 H,
CH2C(NO2)], 4.02 [dd, 2J = 17.4, 3J = 11.9 Hz, 1 H, CH2C(NO2)],
6.10 (dd, 3J = 7.1, 11.9 Hz, 1 H, CHO).
D2-Isoxazolines 2,11 4a–d, 6a–d, and 8 from Isoxazolidines; Gen-
eral Procedure
13C NMR (DMSO-d6): d = 36.6 (CH2), 73.0 (CH), 117.0 (CN),
168.2 [C(NO2)].
A solution of isoxazolidine (1 mmol) in chlorobenzene (3 mL) was
1
refluxed until the starting material had disappeared (TLC and H
NMR). The products were isolated after column chromatography or
recrystallization.
1-(3-Nitro-4,5-dihydroisoxazol-5-yl)ethanone (6c)
Solid; mp 60–61 °C (EtOH); Rf 0.31 (CHCl3).
1H NMR (CDCl3): d = 2.26 (s, 3 H, CH3), 3.50 [dd, 2J = 18.2,
3J = 12.6 Hz, 1 H, CH2C(NO2)], 3.71 [dd, 2J = 18.2, 3J = 7.4 Hz, 1
H, CH2C(NO2)], 5.32 (dd, 3J = 7.4, 12.7 Hz, 1 H, CHO).
13C NMR (CDCl3): d = 26.5 (CH3), 31.7 (CH2), 89.8 (CH), 163.2
[C(NO2)], 202.0 (CO).
3-Nitro-5-phenyl-4,5-dihydroisoxazole (4a)9,10
Solid; mp 65 °C (Lit.9,10 mp 64–65 °C); Rf 0.46 (PE–EtOAc, 4:1).
1H NMR (CDCl3): d = 3.52 (dd, 2J = 17.9, 3J = 6.8 Hz, 1 H, CH2),
3.90 (dd, 2J = 17.9, 3J = 11.7 Hz, 1 H, CH2), 6.10 (dd, 3J = 9.8, 11.7
Hz, 1 H, CHO), 7.35–7.51 (m, 5 H, Ph).
13C NMR (CDCl3): d = 38.0 (CH2), 89.5 (CH), 126.1 (2 × Ph-CH),
129.3 (2 × Ph-CH), 129.7 (Ph-CH), 137.5 (Ph-C), 163.0 [C(NO2)].
Anal. Calcd for C5H6N2O4: C, 37.98; H, 3.82; N, 17.72. Found: C,
C 37.97; H, 3.85; N, 17.55.
Methyl 5-Methyl-3-nitro-4,5-dihydroisoxazole-5-carboxylate
(6d)
Oil; Rf 0.19 (PE–EtOAc, 4:1).
5-Butoxy-3-nitro-4,5-dihydroisoxazole (4b)
Oil; Rf 0.49 (PE–EtOAc, 4:1).
1H NMR (CDCl3): d = 0.85–1.01 (m, 3 H, CH3), 1.26–1.48 (m, 2 H,
CH2), 1.51–1.72 (m, 2 H, CH2), 3.34 [dd, 2J = 18.4, 3J = 2.5 Hz, 1
H, CH2C(NO2)], 3.57 [dd, 2J = 18.4, 3J = 7.1 Hz, 1 H, CH2C(NO2)],
3.63 (dt, 2J = 9.6, 3J = 6.6 Hz, 1 H, CH2), 3.93 (dt, 2J = 9.6, 3J = 6.4
Hz, 1 H, CH2), 5.92 (dd, 3J = 2.5, 7.1 Hz, 1 H, CHO).
13C NMR (CDCl3): d = 13.7 (CH3), 19.1 (CH2), 31.4 (CH2), 36.9
[CH2C(NO2)], 69.7 (CH2O), 109.0 (CHO), 161.5 [C(NO2)].
1H NMR (CDCl3): d = 1.80 (s, 3 H, CH3), 3.38 [d, 2J = 18.1 Hz, 1
2
H, CH2C(NO2)], 3.87 (s, 3 H, CH3), 4.03 [d, J = 18.1 Hz, 1 H,
CH2C(NO2)].
13C NMR (CDCl3): d = 23.6 (CH3), 39.7 [CH2C(NO2)], 53.9
(CH3O), 92.9 (C), 162.2 [C(NO2)], 169.6 (COOCH3).
Anal. Calcd for C6H8N2O5: C, 38.30; H, 4.29. Found: C, 38.58; H,
4.45.
Anal. Calcd for C7H12N2O4: C, 44.68; H, 6.43. Found: C, 44.49; H,
6.81.
11-Nitro-9-oxa-10-azadispiro[3.0.3.3]undec-10-ene (8)
Oil; Rf 0.78 (PE–EtOAc, 4:1).
3-Nitro-1-oxa-2-azaspiro[4.5]dec-2-ene (4c)
Solid; mp 50–51 °C; Rf 0.50 (PE–EtOAc, 4:1).
1H NMR (CDCl3): d = 1.39–1.54 (m, 4 H, CH2), 1.68–1.96 (m, 6 H,
CH2), 3.18 (s, 2 H, CH2).
13C NMR (CDCl3): d = 22.7 (2 × CH2), 24.4 (CH2), 36.4 (2 × CH2),
40.3 [CH2C(NO2)], 96.6 (C), 162.5 [C(NO2)].
1H NMR (CDCl3): d = 1.76–1.87 (m, 1 H, CH2), 1.92–2.05 (m, 1 H,
CH2), 2.07–2.18 (m, 1 H, CH2), 2.23–2.33 (m, 1 H, CH2), 2.35–2.45
(m, 2 H, CH2), 2.46–2.57 (m, 2 H, CH2), 2.60–2.73 (m, 4 H, CH2).
13C NMR (CDCl3): d = 13.5 (CH2), 15.7 (CH2), 26.1 (2 × CH2),
30.0 (2 × CH2), 51.6 (CBr), 100.1 (C), 168.0 [C(NO2)].
Anal. Calcd for C9H12N2O3: C, 55.09; H, 6.16. Found: C, 54.71; H,
6.51.
Anal. Calcd for C8H12N2O3: C, 52.17; H, 6.57; N, 15.21. Found: C,
52.69; H, 6.57; N, 15.35.
4-Nitro(1-nitrocyclobutyl)butan-1-one (9a)
Yield: 0.09 g (42%); oil; Rf 0.40 (PE–EtOAc, 4:1).
3-Nitro-4,5-dihydroisoxazol-5-yl Acetate (4d)9
Oil; Rf 0.31 (CHCl3).
1H NMR (CDCl3): d = 2.16 (s, 3 H, CH3), 3.48 [dd, 2J = 18.9,
3J = 2.0 Hz, 1 H, CH2C(NO2)], 3.59 [dd, 2J = 18.9, 3J = 7.6 Hz, 1 H,
CH2C(NO2)], 6.98 (dd, 3J = 2.0, 7.6 Hz, 1 H, CHO).
13C NMR (CDCl3): d = 19.5 (CH3), 35.9 [CH2C(NO2)], 99.9
(CHO), 164.2 [C(NO2)], 169.0 (OCOCH3).
1H NMR (CDCl3): d = 1.80–1.92 (m, 1 H, CH2), 1.95–2.05 (m, 1 H,
3
3
CH2), 2.29 (q, J = 6.8 Hz, 2 H, CH2), 2.65 (t, J = 6.8 Hz, 2 H,
CH2CO) 2.69–2.84 (m, 4 H, CH2), 4.41 (t, 3J = 6.8 Hz, 2 H,
CH2NO2).
13C NMR (CDCl3): d = 13.4 (CH2), 21.0 (CH2), 30.5 (2 × CH2),
32.1 (CH2), 74.0 (CH2NO2), 92.9 (C), 198.1 (CO).
Anal. Calcd for C8H12N2O5: C, 44.44; H, 5.59. Found: C, 44.46; H,
5.76.
5-(Diethoxymethyl)-3-nitro-4,5-dihydroisoxazole (6a)
Oil; Rf 0.55 (PE–EtOAc, 4:1).
Synthesis 2006, No. 4, 706–710 © Thieme Stuttgart · New York